Shilpa Medicare has received approval from Board of Directors for transfer of API Business of the Company consisting of Unit-1 and Unit-2 situated at Raichur, Karnataka by way of slump sale to a wholly Owned Subsidiary (WOS) of the Company (to be incorporated) subject to the approval of Shareholders.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
